Anti-infective therapies encompass a diverse array of treatments designed to combat microbial infections and improve patient outcomes. Antibiotics, a cornerstone of these therapies, target bacterial infections through various mechanisms, disrupting bacterial cell walls or inhibiting protein synthesis. Antiviral medications are vital in managing viral infections, with drugs like acyclovir and ritonavir inhibiting the replication of viruses such as herpes and HIV. Antifungal agents like amphotericin B address fungal infections, crucial in scenarios like systemic candidiasis. Combating emerging infectious diseases often requires a multifaceted approach. Vaccines, a proactive form of anti-infective therapy, stimulate the immune system to recognize and neutralize pathogens, preventing infections. Additionally, advancements in immunomodulatory drugs contribute to enhancing the body's natural defense mechanisms against infections. As the landscape of infectious diseases evolves, ongoing research strives to develop innovative anti-infective therapies, emphasizing the importance of a dynamic and adaptable approach to disease management.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation